blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2125778

EP2125778 - CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.12.2012
Database last updated on 07.10.2024
Most recent event   Tooltip21.12.2012Application deemed to be withdrawnpublished on 23.01.2013  [2013/04]
Applicant(s)For all designated states
Millennium Pharmaceuticals, Inc.
40 Landsdowne Street
Cambridge, MA 02139 / US
[2009/49]
Inventor(s)01 / ADAMS, Ruth S.
57 Savin Street
Medford, MA 02155 / US
02 / DUFFEY, Matthew
38-B Raymond Avenue
Somerville, MA 02144 / US
03 / GOULD, Alexandra E.
23R Fairmont Street
Cambridge, MA 02139 / US
04 / GREENSPAN, Paul D.
8 Overlook Drive
Acton, MA 01720 / US
05 / KULKARNI, Bheemashankar A.
132 North Street, 4
Newton, MA 02460 / US
06 / VOS, Tricia J.
203 Woburn Street
Medford, MA 02155 / US
 [2009/49]
Representative(s)Harris, Jennifer Lucy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2009/49]Harris, Jennifer Lucy, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date07853440.119.12.2007
[2009/49]
WO2007US26034
Priority number, dateUS20060876688P22.12.2006         Original published format: US 876688 P
[2009/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008079277
Date:03.07.2008
Language:EN
[2008/27]
Type: A1 Application with search report 
No.:EP2125778
Date:02.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application.
[2009/49]
Search report(s)International search report - published on:EP03.07.2008
ClassificationIPC:C07D401/04, C07D409/14, C07D413/14, A61P35/00, A61K31/4155
[2009/49]
CPC:
C07D409/14 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07D401/04 (EP,US); C07D413/14 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/49]
TitleGerman:BESTIMMTE PYRAZOLINDERIVATE MIT KINASEHEMMENDER WIRKUNG[2009/49]
English:CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY[2009/49]
French:CERTAINS DÉRIVÉS DE PYRAZOLINE AVEC UNE ACTIVITÉ INHIBITRICE DE KINASE[2009/49]
Entry into regional phase22.07.2009National basic fee paid 
22.07.2009Designation fee(s) paid 
22.07.2009Examination fee paid 
Examination procedure21.07.2009Amendment by applicant (claims and/or description)
22.07.2009Examination requested  [2009/49]
04.05.2010Despatch of a communication from the examining division (Time limit: M06)
15.11.2010Reply to a communication from the examining division
03.07.2012Application deemed to be withdrawn, date of legal effect  [2013/04]
03.09.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/04]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.05.2010
Fees paidRenewal fee
28.12.2009Renewal fee patent year 03
27.12.2010Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.12.201105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO03079973  (MERCK & CO INC [US], et al) [X] 1-34 * page 12, Formula II; page 16 *;
 [A]WO2006007496  (MERCK & CO INC [US], et al) [A] 1-34 * claim 1 *
by applicant   - CHILOECHES; MARAIS, Targets for Cancer Therapy; Transcription Factors and Other Nuclear Proteins, HUMANA PRESS, (2002), pages 179 - 206
    - MARAIS ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 4378 - 4383
    - PEYSSONNAUX; EYCHENE, BIOL. CELL, (2001), vol. 93, pages 53 - 62
    - WELLBROCK ET AL., CANCER RES., (2004), vol. 64, pages 2338 - 2342
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.